Combination of brimonidine and timolol for topical ophthalmic use
AssigneeAllergan, Inc.
InventorsChin-Ming Chang, Gary J. Beck, Cynthia C. Pratt, Amy L. Batoosingh
Life of this patent
Estimating the term…
Abstract
Disclosed are pharmaceutical compositions comprising brimondine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans.
Claims25
An ophthalmic pharmaceutical composition useful in the treatment of glaucoma or ocular hypertension comprising an effective amount of brimonidine and an effective amount of timolol in a pharmaceutically acceptable carrier therefor.
An article of manufacture comprising packaging material and a pharmaceutical agent contained within said packaging material, wherein the pharmaceutical agent is therapeutically effective for lowering intraocular pressure and wherein the packaging material comprises a label which indicates the pharmaceutical agent can be used for lowering intraocular pressure and wherein said pharmaceutical agent comprises effective amount of brimonidine and an effective amount of timolol.
Dependencies are inferred from the claim text.